29 August 2024
29 August 2024
With the CE mark in hand, Vitestro is now looking to roll out its automated blood drawing device.
DERM’s effectiveness suggests potential cost savings for the NHS, with an estimated return of £2.30 for every £1 invested, and £86 saved per case.
Life Molecular Imaging’s PI-2620 tracer compound has received FDA fast track designation across three neurodegenerative conditions.
The system's capabilities are expected to address critical challenges in the healthcare sector.
OxiWear's ear-worn device is tailored for continuous, real-time monitoring of blood oxygen saturation and pulse rate.
The Pylo OX1-LTE oximeter can provide blood oxygen saturation and pulse rate readings with high accuracy.
The system consists of an endovascularly implantable CSF shunt and delivery components for bypass invasive surgery.
The cost-efficient BYOD ePRO solution aims to streamline clinical trials by using patients' devices.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
